Speaker illustration

Doctor Flavia Fusco

AO dei Colli - Monaldi Hospital, Naples (Italy)

Member of:

European Society of Cardiology

Myocardial work indices and ventricular dyssynchrony in adults with aortic coarctation

Event: EuroEcho 2021

Topic: Congenital Heart Disease

Session: e-posters session - Echocardiography

Thumbnail

Prognostic relevance of thyroid disease in adults with congenital heart disease

Event: ESC Congress 2021 - The Digital Experience

Topic: Adult Congenital Heart Disease (ACHD)

Session: Congress committee e-posters choice in valvular

Thumbnail

Effects of sacubitril/valsartan in patients with a systemic right ventricle: early evidence of exercise tolerance and systolic function improvement

Event: ESC Congress 2021 - The Digital Experience

Topic: Adult Congenital Heart Disease (ACHD)

Session: Congress committee e-posters choice in valvular

Thumbnail

Long-term follow-up after percutaneous pulmonary valve implantation: sustained clinical benefit with evidence of persistent biventricular reverse remodeling and improved global performance

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Intervention

Session: Congenital Heart Disease and Pediatric Cardiology ePosters

Thumbnail

Ruptured Sinus of Valsalva: clinical and echocardiographic features at presentation and long-term results after surgical and percutaneous repair.

Event: EuroEcho 2019

Topic: Imaging of Congenital Heart Disease

Session: Imaging: Congenital Heart Disease

Thumbnail

An unusual vegetation on a prosthetic pulmonary valve

Event: EuroEcho 2019

Topic: Imaging of Congenital Heart Disease

Session: Complex cases and complications in cardiovascular heart disease

Thumbnail

Role of serum biomarkers combined with two-dimensional speckle tracking echocardiography for screening of immunotherapy-induced cardiotoxicity

Event: EuroEcho 2019

Topic: Tissue Doppler, Speckle Tracking and Strain Imaging

Session: Tissue Doppler, Speckle Tracking and Strain Imaging

Thumbnail

This platform is supported by

logo Novo Nordisk